Introduction
The cardiac fatty acid-binding protein is one type of a family of nonenzymic proteins [ I , 21 [ 41, however. reveals a type-specific compartmentation of FAHPs, e.g. the cardiac-type FAHP is associated with myofibrils and mitochondrial matrix, whereas in hepatocytes the so-called hepatic-type FAHP is associated with the endoplasmic reticulum and the outer membrane of mitochondria [S] . Interestingly, both FAHP types are also found inside the nucleus 14, 51. From the abundance of FAHP in tissues with 'active' lipid metabolism and the ability to bind fatty acids with high affinity, an involvement of these proteins in fatty acid metabolism was inferred. Already in the early days of FAHP research a variety of studies related to this field was undertaken even though the proteins were often not available in pure form and structurally not characterized. With the advent of detailed structural information functions were proposed in a more rationalized manner for the nonenzymic FAHPs, e.g. roles in signal transduction and in regulation of cell growth.
Dissecting the structure of cardiac fatty acid-binding protein
The cI)NA for bovine heart FAHI' [ h ] codes for a 132 amino acid protein with a high proportion of P-sheet, as predicted from secondary structure calculations. Plasma desorption Inass spectrometry indicates a molecular mass of 14675, k 10 Da for the purified protein 17 I in good agreement with that deduced from the cI)NA, if one takes into account that the protein is N-terminally blocked by an acetyl group. The latter finding was corroborated by mass analysis of N-terminal peptides. In many cases FAHPs occur as isoforms that differ in their charge; for example cardiac FAHP from bovine heart has pl 4.9-and pI 5. sequence determination o f the puritied isotorms pin-pointed the molecular basis for this heterogeneity to a single asparagine/aspartate vxchange in position 98 [ 7 ] . The pI S.1 -isoform with asparagine in this position was co-linear to the cI )NA (Fig. 1 a ) and the question arose. whether the two charge isoforms are translated from different niKNAs or result from post-translational deamidation, be it spontaneous or enzymic. Analysis by isoelectric focusing of immunoprecipitated ['is Imethioninelabelled products translated in vitro from total mRNA of bovine heart and from positive hybrid selected cardiac FAHI'-mRNA on the one hand showed two proteins that co-migrated with the authentic pI 4.9-and pI 5.1-isofomis. On the other hand translation of recombinant mIINA derived from the cDNA encoding the pI 5.1-isoform produced indeed the pI 5.1-isoform only (N. Hartetzko & F. Spener, unpublished work) . 'I'he result of these experiments demonstrates that each isoform is encoded by its specific mKNA and precludes posttranslational deamidation. Interestingly, only the pI 4.9-isoform is found in the mitochondria1 matrix. Whether a specific import mechanism is responsible for this phenomenon is currently under investigation.
Tertiary Firstly, the a-helices from positions 15 to 35 form an a-helix/turn/a-helix motif well known for a class of DNA-binding proteins. Taking into account that cardiac FABP is present in the nucleus, one may speculate over a role for this protein in gene regulation. Work is in progress to study the import of cardiac FABP and of mutants lacking the ahelix/turn/a-helix motif into the nucleus and their interaction with DNA. Secondly, a consensus sequence for tyrosine phosphorylation is present around Tyr", which may indicate that cardiac FABP is a target in signal transduction. Thirdly, a stunning 96% homology of cardiac FABP to a 'mammary derived growth inhibitor' is noticed. The latter two findings are discussed in more detail in the last two sections.
Modulation of fatty acid metabolism
Among the functions that have been proposed for FABP and that we may call functions of the first generation are: (i) to serve as a pool for solubilized fatty acids, (ii) to promote the cellular uptake of fatty acids and their utilization, (iii) to protect enzymes from detergent effects of fatty acids, (iv) to modulate enzyme activities and (v) to facilitate targetted transport of fatty acids to specific metabolic pathways (Fig. 2b) . Here we shall discuss the modulation of acyl-CoA ligase and of enzymes of the P-oxidative system in bovine heart mitochondria.
The functional aspect of compartmentation of cardiac FABP in the cytosol and mitochondrial matrix of myocytes was tested under the following working hypothesis: under conditions of low carbohydrate supply the heart cell gains 75% of the energy needed from the oxidation of fatty acids. Thus upon uptake of fatty acids from the blood into the cell, they partition into the cytosol for transport to the outer mitochondrial membrane, where they are activated by acyl-CoA ligase, a prerequisite for import of the fatty acid into the mitochondrial matrix and subsequent degradation via P-oxidation. In this intracellular path cardiac FARP may interfere in a 2-fold manner: firstly, binding the fatty acid in the cytosol by FABP promotes a targetted transport and/or modulates the activity of the acyl-CoA ligase, and secondly, the FABP in the matrix may modulate fatty acid oxidation. This rationale was tested experimentally in vitro with intact and broken mitochondria, respectively (J. Hassink, H. Rude1 &
F. Spener, unpublished work).
Under optimized conditions intact mitochondria were monitored for acyl-CoA ligase activity with 14C-labelled palmitic, oleic and arachi- Unreacted fatty acids were removed by solvent extraction and the amount of newly synthesized acyl-CoAs in the aqueous phase was determined by liquid scintillation counting (Fig. 2a) The functional significance of mitochondrial localization of cardiac FABP for the degradation of acyl-CoAs was studied by incubating broken mitochondria with palmitoyl-CoA and oleoyl-CoA as substrates, again in the absence and in the presence of varying amounts of FABP. The assay system is based on the reduction of dichlorophenolindophenol by acyl-CoA dehydrogenases [ 151 and was optimized in the presence of KCN to inhibit mitochondria] respiration. With a substrate concentration of 10 ,UM acyl-CoA we observed in the presence of up to 20 ,UM cardiac FABP a decrease in the reaction rate of about 50%. When the acylCoA concentration was varied at a concentration of FABP fixed at 10 ,UM, the rate of oxidation at 5-10 ,UM acyl-CoA was lower, but at elevated acyl-CoA concentrations, up to 30 ,UM, the rate of oxidation Volume 20 was higher than that without cardiac FABP in the assay system. One explanation is that the concentration of 'free' acyl-CoA, which inhibits the acyl-CoA dehydrogenase is lower in the presence of cardiac FABP. It is possible that the FABP presented under physiological conditions to the mitochondria1 matrix modulates the activities of the /?-oxidative enzymes. Under anoxic conditions, when the concentration of acyl-CoAs in the heart rises, cardiac FABP may prevent the enzymes from being inhibited.
Phosphorylation of cardiac fatty acidbinding protein
Studies on the phosphorylation of proteins in 3T3-I,1 cells revealed the adipocyte FABP as cellular target of the insulin receptor tyrosine kinase [ 16, 171. Insulin-dependent phosphorylation occurred at TyrI9, which is part of the well known consensus sequence for tyrosine kinases, Asn-Phe-Asp-AspTyr, a sequence also present in the first a-helix domain of cardiac FABP. It was thus conceivable that cardiac FABP takes part in insulin-dependent signal transduction, as insulin receptors are located in the plasma membrane of heart muscle cells as well. Our experimental model comprised a primary culture of adult rat heart myocytes treated with ortho-vanadate and phenylarsineoxide to inhibit phosphatase action and, concomitantly, to allow for accumulation of phosphorylated species (S. U.
Nielsen & F. Spener, unpublished work). Myocytes were isolated via Langendorff perfusion of rat heart and after incubation with ["P]phosphate in the presence of insulin, cytosolic proteins were separated by two-dimensional gel electrophoresis and blotted onto PVDF-membranes. Autoradiography of blots revealed several -15 kDa proteins among phosphoproteins, yet only one of these could be precipitated specifically by affinity purified polyclonal antibodies. As expected, this spot did not match with either of the two isoforms of rat cardiac FABP observed after immunostaining, as the addition of the negatively charged phosphate moiety results in the PI of the phosphoprotein being slightly more acidic than that of the minor isoform. The amount of rat cardiac FABP actually phosphorylated was estimated to be clearly below -0.5% of total cardiac FABP in accordance with data on the phosphorylated adipocyte FABP, which indicate a stoichiometry for phosphorylation of 0.2% [ 171. In experiments where insulin was omitted during incubation with ["P]phosphate, phosphorylated cardiac FABP was detected in autoradiograms only in minute amounts, if at all. This does not prove but certainly is in support of our hypothesis that cardiac FABP is an intracellular target of the insulin receptor tyrosine kinase. Further support came from the identification of the cardiac FABP was purified from radioactively labelled myocytes to near homogeneity in one step by immunoaffinity chromatography and submitted to tryptic peptide mapping. T.1.c. analysis together with radiosequencing of the major phosphopeptide clearly established Tyr19 as substrate for the kinase.
The low degree of phosphorylation observed in vivo precludes an effect on the gross flow of fatty acids, as may be deduced from the recent finding that phosphorylation of adipocyte FABP virtually abolishes fatty acid binding [18] . Together with a 10-fold reduction in K , for phosphorylation of lipidated adipocyte FABP compared with the apo FABP [ 191, an insulin-dependent cycling of fatty acids from the plasma membrane to the endoplasmic reticulum for eventual utilization was suggested. Considering the 500-fold excess of unphosphorylated FABP, however, that reportedly also has the potential to target fatty acids between membranes [20, 211 this catalytical model appears rather unlikely. Nevertheless, it is tempting to speculate that phosphorylation of FABP provides an early intermediate in the signalling chain from activated insulin receptor to enzymes of lipid metabolism. A possible role for FABP in this transduction is the sensing of the intracellular fatty acid concentration. Whether the phosphorylated FABP interacts with other intermediates of the signalling chain or directly with some specific regulative elements of genes for enzymes of lipid metabolism [22] is not known at present. phosphorylated amino acid. For this purpose rat a09
Inhibition of cell growth
In the course of studies on mammary gland morphogenesis and the role of regulatory polypeptides controlling growth, differentiation and regression of the mammary epithelium, a factor was isolated from bovine lactating mammary gland with inhibitory action on various normal and transformed mammary epithelial cell lines [23] . This factor, named mammary derived growth inhibitor (MDGI), surprisingly shares with cardiac FABP from bovine heart a very high sequence identity. In Fig. l(a) the seven amino acids that differ in the primary structure of both proteins are marked. Due to its binding capacity for fatty acids [24] , its immunological cross-reactivity, its localization in 2D-gels and its abundance, MDGI may be regarded as an isoform of cardiac FABP. However, the growth inhibitory action is not connected to binding of ligands, as a synthetic peptide spanning amino acids Thr"l-Gln121 (shaded in Fig. l b ) also inhibits growth of Ehrlich ascites mammary tumor cells, although two orders of magnitude less effectively than the whole protein [25] . Bovine heart cardiac FARP has no inhibitory effect in this proliferation assay despite its similarity to bovine MDGI (Fig. 3) .
T o exclude the possibility that the manner of purification affects the inhibitory activity or that minute impurities of authentic MDGI were responsible for the biological action, we employed recombinant proteins in the comparison of MDGI and cardiac FARP. Efforts to clone a cDNA coding for MDGI from lactating bovine mammary gland were not successful, in fact, only a cDNA encoding the PI 5.1-isoform of cardiac FARP was obtained [26] . Thus, by site directed mutagenesis [27] , cardiac FARP was sequentially transformed to MDGI. From corresponding cDNAs highly productive expression vectors based on the PET system [28] were constructed and the respective recombinant FARP, mutants and eventually the recombinant MDGI were overexpressed in Escherichiu coli strain RL2 1 (DE3). Recombinant proteins comprised up to 40% of cytosolic proteins and were purified to homogeneity by a combination of cation exchange 
Conclusion
FABPs are more and more understood at the level of primary structure: the molecular origin of isoforms, the mechanism of ligand binding and even tertiary structures are being unravelled. Yet the physiological function of FABP in vivo still remains enigmatic and a more diverse role in cellular function than previously appreciated has to be envisaged as discussed in the last two sections. Progress in our understanding of FARP may arise from studies of the regulation of the protein at the genomic level [29] , e.g. promotor analysis, and from transfection experiments either with sense or antisense constructs.
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Introduction
incubated with tritiated dihydro DIDS demonDi-isothiocyanodisulphonic acid (DIDS) is a potent strated a prominent peak of radioactivity associated irreversible inhibitor of oleate transport in rat with membrane component(s) migrating like a proadipocytes. Gel electrophoresis of plasma memtein of M , 80000 to 90000 implicating it in the branes isolated from rat adipocytes which had been membrane transport of fatty acids (FAs). However, two concerns limited data interpretation. T h e first one related to the lack of specificity of the compound which, at the concentrations required to pro- 
